CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos

Area of Science:

• Molecular Biology
• Developmental Biology
• Genetics

Background:

• Early embryonic development relies on maternal gene products.
• Understanding maternal gene function is crucial but challenging due to limited disruption techniques.
• CRISPR-Cas13 systems show promise for RNA degradation in various cell types.

Purpose of the Study:

• To evaluate CRISPR-RfxCas13d (CasRx) as a tool for systematic gene function analysis in animal embryos.
• To assess the efficacy of CasRx in depleting both zygotically expressed and maternally provided transcripts.
• To determine the applicability of CasRx in diverse animal models.

Main Methods:

• Utilized CRISPR-RfxCas13d (CasRx) to target specific mRNA transcripts in zebrafish embryos.
• Quantified transcript level reduction following CasRx treatment.
• Assessed the resulting embryonic phenotypes.
• Tested CasRx efficacy in medaka, killifish, and mouse embryos.

Main Results:

• Achieved efficient and precise depletion of target mRNA transcripts.
• Demonstrated an average decrease of 76% in transcript levels.
• Successfully recapitulated known embryonic phenotypes.
• Confirmed CasRx effectiveness in medaka, killifish, and mouse embryos.

Conclusions:

• CRISPR-RfxCas13d (CasRx) is a highly effective RNA knockdown platform for interrogating gene function in animal embryos.
• CasRx provides a powerful new tool for developmental biology research across multiple species.
• This system overcomes previous limitations in studying maternal gene function during embryogenesis.